HansBiomed Corporation (KOSDAQ:042520)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,600.00
+210.00 (2.50%)
At close: Jul 11, 2025, 3:30 PM KST

HansBiomed Revenue

HansBiomed had revenue of 24.16B KRW in the quarter ending March 31, 2025, with 18.10% growth. This brings the company's revenue in the last twelve months to 84.36B, up 7.75% year-over-year. In the fiscal year ending September 30, 2024, HansBiomed had annual revenue of 81.14B with 3.98% growth.

Revenue (ttm)
84.36B
Revenue Growth
+7.75%
P/S Ratio
1.28
Revenue / Employee
320.74M
Employees
263
Market Cap
108.18B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Sep 30, 2024 81.14B 3.11B 3.98%
Sep 30, 2023 78.03B 3.57B 4.80%
Sep 30, 2022 74.46B 15.36B 25.99%
Sep 30, 2021 59.10B -21.00B -26.22%
Sep 30, 2020 80.10B 13.11B 19.57%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.10T
SK hynix 71.40T
LG Energy Solution 25.76T
Samsung Biologics 4,898.69B
Hyundai Motor Company 178.98T
KB Financial Group 14.93T
Celltrion 3,662.23B
Kia Corporation 109.25T
Revenue Rankings